A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir

NCT02323594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Infection

Interventions

DRUG: Daclatasvir
DRUG: Daclatasvir
DRUG: Asunaprevir
DRUG: Daclatasvir

Sponsor

Bristol-Myers Squibb